General form of registration statement for all companies including face-amount certificate companies

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT)

v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment
Accumulated deficit
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional paid-in capital
Accumulated deficit
Total
Beginning Balances at Dec. 31, 2021     $ 1 $ 43,399 $ (14,444) $ 28,956
Beginning Balances (in shares) at Dec. 31, 2021     645,943      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options       4   4
Exercise of stock options (in shares)     40      
Share issuance, net       5,195   5,195
Share issuance, net (in shares)     278,804      
Stock-based compensation       1,420   1,420
Stock-based compensation (in shares)     126,311      
Tax impact of equity transactions       2   2
Net loss         (30,112) (30,112)
Ending Balance at Dec. 31, 2022     $ 1 50,020 (44,556) 5,465
Ending Balance (in shares) at Dec. 31, 2022     1,051,098      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share issuance, net       300   300
Share issuance, net (in shares)     50,000      
Stock-based compensation       (10)   (10)
Net loss         (3,144) (3,144)
Ending Balance at Mar. 31, 2023     $ 1 50,310 (47,700) 2,611
Ending Balance (in shares) at Mar. 31, 2023     1,101,098      
Beginning Balances at Dec. 31, 2022     $ 1 50,020 (44,556) 5,465
Beginning Balances (in shares) at Dec. 31, 2022     1,051,098      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss           (9,196)
Ending Balance at Jun. 30, 2023           1,564
Beginning Balances at Dec. 31, 2022     $ 1 50,020 (44,556) 5,465
Beginning Balances (in shares) at Dec. 31, 2022     1,051,098      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss           (16,635)
Ending Balance at Sep. 30, 2023           (5,834)
Beginning Balances at Dec. 31, 2022     $ 1 50,020 (44,556) 5,465
Beginning Balances (in shares) at Dec. 31, 2022     1,051,098      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of warrants (in shares)     750,000      
Share issuance, net     $ 5 5,378   5,383
Share issuance, net (in shares)     4,091,667      
Share issuance, acquisition related     $ 1 204   205
Share issuance, acquisition related (in shares)     547,946      
Stock-based compensation       (300)   (300)
Stock-based compensation (in shares)     268,581      
Tax impact of equity transactions       (10)   (10)
Net loss         (26,078) (26,078)
Fractional shares issued related to reverse split (shares)     11,168      
Ending Balance at Dec. 31, 2023     $ 7 55,292 (70,634) (15,335)
Ending Balance (in shares) at Dec. 31, 2023     6,720,460      
Beginning Balances at Mar. 31, 2023     $ 1 50,310 (47,700) 2,611
Beginning Balances (in shares) at Mar. 31, 2023     1,101,098      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss           (6,052)
Ending Balance at Jun. 30, 2023           1,564
Beginning Balances at Dec. 31, 2023     $ 7 55,292 (70,634) (15,335)
Beginning Balances (in shares) at Dec. 31, 2023     6,720,460      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation       174   $ 174
Stock-based compensation (in shares)     268,758     268,758
Net loss         (3,761) $ (3,761)
Convertible debt converted into common shares     $ 1 333   334
Convertible debt converted into common shares (in shares)     1,337,371      
Ending Balance at Mar. 31, 2024 $ (22) $ (22) $ 8 $ 55,799 $ (74,417) $ (18,610)
Ending Balance (in shares) at Mar. 31, 2024     8,326,589